Sales of General Medicines were up 7% during the quarter. This upside was driven by solid sales growth of the asthma inhaler Trelegy Ellipta across all regions, reflecting patient demand.

In a “true pivot” in asthma care across the UK, new guidelines urge medics to offer inhalers that both relieve and prevent symptoms to newly diagnosed sufferers who are 12 and over ...

Asthma patients to be shown leaflets detailing climate impact of inhalers as NHS estimates they account for 3pc of their carbon footprint Doctors have been told to stop prescribing blue inhalers ...

We need better utilisation of funding, more clinicians, and greater access to diagnostics,” he said. Amanda Southcombe, General Manager of GSK NZ, said recent funding for Trelegy Ellipta, a ...

Amanda Southcombe, GSK NZ General Manager, says funding for Trelegy Ellipta was recently announced, a single inhaler triple-therapy to treat the disease, which will see around 15,000 Kiwis suffering ...

Amanda Southcombe, GSK NZ General Manager, says funding for Trelegy Ellipta was recently announced, a single inhaler triple-therapy to treat the disease, which will see around 15,000 Kiwis suffering ...

Inhaler have announced a spring 2025 North American tour, kicking off at the end of February next year. The Dublin band – comprised of Eli Hewson, Rob Keating, Josh Jenkinson and Ryan McMahon ...